drugset / Trial / NCT04287777

Safety and Efficacy of Mupirocin Gel in Children With Impetigo

NCT04287777

Phase 3 Completed 467 enrolled Reig Jofre Group
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to show non inferiority in terms of safety and efficacy of topical administration BID (Twice daily) of Mupirocin Gel 20 mg/g compared to topical administration of Mupirocin Ointment 20 mg/g TID (three times daily) (Bactroban) in the treatment of impetigo in paediatric population.

Timeline

Start
2014-02
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Mupirocin Small molecule 20 unknown Topical

Indications